Molecular Imaging

FluoroPharma Expands Board of Directors and Scientific Advisory Board

Published in Physician Law Weekly, August 15th, 2007

FluoroPharma Inc., a company developing breakthrough cardiovascular PET molecular imaging diagnostics, announced that Dr. Todd R. Nelson joined FluoroPharma's Board of Directors as an Independent Director, and Dr. Elazer Edelman joined FluoroPharma's Scientific Advisory Board.

Dr. Todd R. Nelson is currently Vice President Corporate Development and Strategy at Invitrogen Corporation and previously was Managing Director and Head, Global Life Sciences Corporate Strategy and Research at the Royal Bank of Canada Capital Markets (formerly Dain Rauscher Wessels) and was First Vice President, Corporate Research and Economics at Merrill Lynch. Throughout his career, Dr. Nelson...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2007-08-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry